PT Medco Energi Internasional Tbk

PT Medco Energi Internasional Tbk, an energy and natural resources company, explores for and produces oil and gas. The company operates 11 exploration and production blocks, 1 development block, and 4 exploration blocks in Natuna, Sumatra, Kalimantan, Java, and Sulawesi in Indonesia; and holds oil and gas assets in the Vietnam, Thailand, Oman, Libya, Yemen, Malaysia, Mexico, and Tanzania. It also engages in the power business; copper and gold mining operations in Sumbawa Island, Nusa Tenggara; and operation of compression station with three gas compressors and 10 pipeline facilities in Gunung Megang, South Sumatra. The company was formerly known as PT Medco Energi Corporation and changed its name to PT Medco Energi Internasional Tbk in 2000. The company was founded in 1980 and is headquartered in Jakarta, Indonesia. PT Medco Energi Internasional Tbk is a subsidiary of PT Medco Daya Abadi Lestari.

PT Medco Energi Internasional Tbk trades as MEYYY on OTC. The company is classified in Energy / Oil & Gas Exploration & Production and reports in USD.

The current profile places the business in Oil & Gas Exploration & Production. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $2.40B of revenue and $367.36M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

PT Medco Energi Internasional Tbk can be compared against peers such as Beach Energy Limited, CIMC Enric Holdings Limited, Freehold Royalties Ltd., International Petroleum Corporation, Japan Petroleum Exploration Co., Ltd., Parex Resources Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $183.55B, beta of 0.57, and return on equity of +17.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

MEYYY currently shows total debt of $3.58B and beta of 0.57. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.medcoenergi.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.